Dentsply - XRAY Debts to Book Capitalization

Corporate company logo of Dentsply Sirona Inc (XRAY)

Serving as a valuation tool, the DENTSPLY SIRONA Inc. (XRAY) price chart demonstrates the dynamics of a dental sector leader implementing eco-friendly waste disposal methods and digital technologies. The business relies on global distribution and a mix of consumables and sophisticated equipment, which mitigates regional risks. The current indicator stands at 1.83, while management restructuring and cost optimization are already yielding results, and the market price currently prices in low demand.

Sirona Dental Systems - XRAY Debt to Book Value (period 07/04/2022 - 10/29/2026)

Dentsply Sirona Inc (XRAY) - metric breakdowns and financial figures

- current price and projected stock value:
Stock Price DENTSPLY SIRONA Inc.|XRAY - Broker Consensus Forecast
- issuer market value details:
Market Capitalization Sirona Dental Systems|XRAY - Company Buyout Price
- issuer book value statistics:
Book Value per Share Dentsply Sirona|XRAY - Company Net Assets|Market Capitalization to Book Value Ratio dentsplysirona.com|XRAY - Company Total Assets
- company liabilities and liquidity data:
Debt to Equity DENTSPLY SIRONA Inc.|XRAY - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Dentsply|XRAY - Aggregate Debt Obligations|Debts to Book Capitalization Sirona Dental Systems|XRAY - Long-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|Quick Liquidity dentsplysirona.com
- financial results and valuation multiples details:
XRAY - Net Financial Result
Summary company analysis:DENTSPLY SIRONA Inc. XRAY
Original product of Sirona Dental Systems

DENTSPLY SIRONA Inc. (XRAY) investments in green plant modernization and circular packaging require strict monitoring of financial stability. This indicator compares total liabilities to equity, determining the business's reliance on borrowed funds and the level of credit risk. Analyzing the current debt-to-book capitalization ratio allows for an assessment of the balance between aggressive growth and investment security.

Analysis of competing companies

Debts to Book Capitalization ISRG (Intuitive Surgical)|DHR: Debt to Book Value Ratio|Becton Dickinson - Debts to Book Capitalization|Debts to Net Assets STERIS PLC STE|WST: Debts to Book Capitalization|Debt to Book Value Baxter Healthcare|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization stevanatogroup.com|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio MMSI (Merit Medical Systems, Inc.)|Envista Holdings Corp - Debt to Book Value|Debt to Net Assets Ratio ICUI|LeMaitre Vascular, Inc. - Debts to Book Capitalization|Debts to Net Assets atricure.com ATRC|STAAR Surgical (STAA) - Debt to Book Capitalization Ratio|Debt to Book Value Ratio NAGE|Debt to Book Capitalization Ratio ZimVie Dental|AngioDynamics Inc. (ANGO) - Debts to Net Assets|Debt to Book Value CERS (Cerus Corporation)|Debt to Book Capital TKNO|Debt to Book Capitalization Ratio Monogram Orthopedics MGRM|Debt to Net Assets Ratio STSS|INFU: Debt to Book Value|UTMD - Debts to Book Capitalization|korumedical.com (KRMD) - Debt to Book Capitalization Ratio|Debt to Book Value nyxoah.com|MBOT (Microbot Medical) - Debts to Book Capitalization|Debts to Book Value Pro-Dex Inc PDEX|Debt to Book Capitalization Ratio Zentek Limited (ZTEK)|Elutia Corporation - Debt to Book Value Ratio|Milestone Scientific - Debt to Book Value|Debt to Book Capital NXGL (nexgel.com)|RVP - Debt to Book Capitalization Ratio|Debts to Net Assets harvardbioscience.com HBIO|FEMY: Debts to Book Capitalization|Debt to Book Value Ratio MHUA|POAI (Predictive Oncology Inc) - Debts to Book Capitalization|Debts to Book Value Callan JMB Corp CJMB|Debt to Book Capitalization Ratio Atrion (ATRI)|NeuroMetrix Inc - Debt to Book Value Ratio